Effects of Astragalus on Secretion and Mrna Expression of TGF-β1 Induced by Peritoneal Dialysis Solution in Cultured Human Peritoneal Mesothelial Cell

XU Hai-hong,ZHANG Miao,JIANG Chun-ming
DOI: https://doi.org/10.3969/j.issn.1009-2501.2005.07.017
2005-01-01
Abstract:AIM: To investigate the effects of Astragalus on peritoneal fibrosis correlating peritoneal dialysis. METHODS: Human peritoneal mesothelial cells (HPMC) were cultured in vitro. They were divided into five groups: RPMI1640 culture medium as control group, PDS(peritoneal dialysis solution)containing (1.5)% glucose as PDS group, PDS containing (1.5)% glucose and Astragalus 10 (mg·ml~(-1)) as Astragalus group 1, PDS containing (1.5)% glucose and Astragalus 20 (mg·ml~(-1)) as Astragalus group 2 and PDS containing (1.5)% glucose and Astragalus 40 (mg·ml~(-1)) as Astragalus group 3 for testing. The levels of TGF-β_1 in supernatant of the cell culture was detected by the method of ELISA and the mRNA expression of TGF-β_1 were tested by the method of reverse transcriptase PCR (RT-PCR) at 24 hours. RESULTS: The level of TGF-β_1 was significant lower in control group than that in PDS group (P(0.05)). Marked lower level of TGF-β_1 was found in Astragalus group 1, Astragalus group 2 and Astragalus group 3 compared with the PDS group (P(0.05)). The mRNA expression of TGF-β_1 increased significantly to (162.43)% compared with the control group. The mRNA expression of TGF-β_1 increased (23.52)% in Astragalus group 1, (21.36)% in Astragalus group 2 and (18.71)% in Astragalus group 3, respectively, and significant difference were found when compared with those in PDS groups (P(0.01)). CONCLUSION: Astragalus inhibits TGF-β_1 protein and mRNA over-expression induced by commercial PDS and plays a beneficial role in peritoneal fibrosis correlating peritoneal dialysis.
What problem does this paper attempt to address?